Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
36.1 /100
Rank 18 out of 27 Sectors -
Advance/Decline
61/151
-
No. of Companies212
-
Avg. Market Cap9,777
-
Price to Earning Ratio33.83
-
Price to Earning Growth Ratio7.19
-
Price to Book Ratio6.47
-
Return on Equity36.72
-
Return on Capital Employed-
-
Return on Assets5.50
-
Dividend yield 1 year %0.27 %
-
Net Profit Growth Annual YoY %0.18 %
-
Net Profit Growth Qtr YoY %-20.11 %
-
Net Profit Growth Qtr QoQ %20.17 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
31,566.7
|
111.7
|
L
 0.0%
H
111.4
112.5
|
L
 0.1%
H
110.3
114.9
|
L
 -11.6%
H
110.3
125.8
|
L
 -18.6%
H
110.3
150.1
|
L
 -8.6%
H
96.4
160.3
|
L
 -16.1%
H
96.4
160.3
|
L
 -9.0%
H
96.4
179.6
|
L
 177.9%
H
38.9
179.6
|
| Amerisource Bergen Corp |
|
-
|
331.7
|
L
 2.0%
H
325.9
334.1
|
L
 -5.9%
H
318.1
356.1
|
L
 -7.6%
H
318.1
376.9
|
L
 -2.7%
H
318.1
376.9
|
L
 14.3%
H
273.4
377.5
|
L
 118.2%
H
150.3
377.5
|
L
 186.2%
H
111.3
377.5
|
L
 279.2%
H
68.4
377.5
|
| Abbott |
|
186,052.8
|
107.1
|
L
 -0.1%
H
106.7
107.8
|
L
 -1.0%
H
106.7
111.9
|
L
 -4.6%
H
106.7
116.8
|
L
 -14.7%
H
105.3
129.5
|
L
 -16.0%
H
105.3
139.1
|
L
 10.4%
H
89.7
141.2
|
L
 -11.0%
H
89.7
142.6
|
L
 162.5%
H
36.8
142.6
|
| Alcon Inc - Registered Shares |
|
36,284.1
|
74.4
|
L
 -0.8%
H
74.4
75.1
|
L
 -5.2%
H
74.4
78.8
|
L
 -10.6%
H
74.4
87.6
|
L
 -6.9%
H
74.4
87.6
|
L
 -18.1%
H
71.6
99.2
|
L
 13.8%
H
65.6
101.1
|
L
 9.2%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,711.8
|
35.8
|
L
 -2.1%
H
35.7
37.0
|
L
 -1.2%
H
35.7
38.1
|
L
 -5.9%
H
34.8
38.8
|
L
 -23.2%
H
33.9
48
|
L
 46.7%
H
22.0
48.3
|
L
 202.7%
H
11.6
48.3
|
L
 53.8%
H
9.6
48.3
|
L
 236.0%
H
9.6
48.3
|
| Avanos Medical Inc |
|
614.8
|
13.2
|
L
 -1.8%
H
13.2
13.8
|
L
 -1.6%
H
13.2
14.3
|
L
 -13.1%
H
12.8
15.7
|
L
 13.3%
H
11.1
15.7
|
L
 -10.8%
H
9.3
15.7
|
L
 -52.4%
H
9.3
31.3
|
L
 -71.2%
H
9.3
46.1
|
L
 -54.5%
H
9.3
73.0
|
| Baxter International |
|
8,602.3
|
16.7
|
L
 0.4%
H
16.5
16.8
|
L
 -7.2%
H
16.4
18.6
|
L
 -21.7%
H
16.4
21.8
|
L
 -11.8%
H
16.4
22.4
|
L
 -51.0%
H
16.4
34.5
|
L
 -55.5%
H
16.4
50.2
|
L
 -79.2%
H
16.4
89.7
|
L
 -58.3%
H
16.4
95.2
|
| Becton, Dickinson and Co. |
|
44,695.4
|
157.1
|
L
 0.4%
H
156.5
158.1
|
L
 -1.6%
H
156.4
163.4
|
L
 -13.9%
H
156.4
187.4
|
L
 -19.7%
H
156.4
213.1
|
L
 -32.2%
H
156.4
233.1
|
L
 -33.3%
H
156.4
287.3
|
L
 -32.6%
H
156.4
287.3
|
L
 7.2%
H
144.1
287.3
|
| Butterfly Network Inc (Class A) |
|
998.2
|
3.9
|
L
 -1.3%
H
3.9
4.0
|
L
 7.7%
H
3.7
4.3
|
L
 28.1%
H
2.8
5.0
|
L
 10.1%
H
2.8
5.0
|
L
 44.7%
H
1.3
5.0
|
L
 98.0%
H
0.7
5.0
|
L
 -78.4%
H
0.7
20.2
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
7,105.2
|
263.3
|
L
 -0.7%
H
262.1
267.7
|
L
 0.6%
H
259.0
272.4
|
L
 -3.2%
H
259.0
288.8
|
L
 -12.7%
H
251
328.6
|
L
 3.6%
H
211.4
343.1
|
L
 -44.0%
H
211.4
494.1
|
L
 -53.7%
H
211.4
832.7
|
L
 99.4%
H
131.3
832.7
|
| Bausch + Lomb Corp |
|
5,612.4
|
15.8
|
L
 -2.0%
H
15.8
16.3
|
L
 -4.5%
H
15.8
16.8
|
L
 -10.3%
H
15.8
18.9
|
L
 -6.7%
H
15.8
18.9
|
L
 2.3%
H
10.5
18.9
|
L
 -0.3%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
104,317.1
|
70.3
|
L
 0.6%
H
69.6
70.6
|
L
 2.6%
H
68.4
71.9
|
L
 -7.2%
H
67.6
76.9
|
L
 -26.5%
H
67.6
100.9
|
L
 -30.2%
H
67.6
109.5
|
L
 46.6%
H
47.5
109.5
|
L
 84.2%
H
35.0
109.5
|
L
 288.0%
H
17.8
109.5
|
| Cardinal Health |
|
48,945.7
|
208
|
L
 -1.4%
H
207.9
212.1
|
L
 -5.1%
H
207.9
222.6
|
L
 -6.6%
H
207.9
233.6
|
L
 2.5%
H
199.9
233.6
|
L
 57.4%
H
120.7
233.6
|
L
 198.8%
H
68.5
233.6
|
L
 254.5%
H
45.9
233.6
|
L
 157.2%
H
39.1
233.6
|
| Conmed Corp |
|
1,127.9
|
36.6
|
L
 -0.6%
H
36.3
36.8
|
L
 -0.4%
H
35.9
38.0
|
L
 -17.9%
H
35.9
47.1
|
L
 -8.4%
H
35.4
47.1
|
L
 -37.9%
H
35.4
61.3
|
L
 -59.5%
H
35.4
138.5
|
L
 -70.9%
H
35.4
159.1
|
L
 -9.5%
H
35.4
159.1
|
| Cooper Companies |
|
13,683.4
|
70.1
|
L
 -0.8%
H
70
70.8
|
L
 -1.9%
H
69.8
73.1
|
L
 -16.2%
H
69.8
84.6
|
L
 -15.3%
H
69.8
85.0
|
L
 -12.5%
H
61.8
89.8
|
L
 -17.9%
H
61.8
112.4
|
L
 -26.9%
H
61.1
115.9
|
L
 87.0%
H
36.7
115.9
|
| Danaher |
|
134,441.3
|
190.1
|
L
 0.0%
H
189.3
191.3
|
L
 2.1%
H
185.2
196.8
|
L
 -10%
H
185.2
212.7
|
L
 -15.4%
H
185.2
242.8
|
L
 -9.6%
H
171.0
242.8
|
L
 -21.7%
H
171.0
281.7
|
L
 -14.0%
H
171.0
334.0
|
L
 163.3%
H
70.1
334.0
|
| Edwards Lifesciences |
|
47,788.2
|
82.3
|
L
 -0.2%
H
81.9
83.0
|
L
 -2.8%
H
81.3
85.3
|
L
 4.3%
H
78
87.3
|
L
 -4.0%
H
74.7
87.4
|
L
 16.1%
H
65.9
87.9
|
L
 1.9%
H
58.9
96.1
|
L
 3.6%
H
58.9
131.7
|
L
 187.7%
H
27.0
131.7
|
| Glaukos Corp |
|
6,064.0
|
104.4
|
L
 2.3%
H
102
104.7
|
L
 6.8%
H
95.9
104.7
|
L
 -10.8%
H
95.9
123.2
|
L
 -10.2%
H
94.0
130.2
|
L
 3.1%
H
73.2
130.2
|
L
 117.4%
H
45.4
163.7
|
L
 18.1%
H
33.3
163.7
|
L
 526.3%
H
15.2
163.7
|
| Globus Medical Inc (Class A) |
|
11,612.8
|
85.9
|
L
 -0.5%
H
85.7
86.3
|
L
 1.6%
H
84.6
88.4
|
L
 -5.6%
H
84.3
97.9
|
L
 -1.4%
H
84.3
101.4
|
L
 17.1%
H
51.8
101.4
|
L
 65.7%
H
43.4
101.4
|
L
 42.0%
H
43.4
101.4
|
L
 259.2%
H
19.3
101.4
|
| Haemonetics Corp |
|
2,713.5
|
58.4
|
L
 -0.9%
H
58.2
59.1
|
L
 -1.9%
H
58.2
60.9
|
L
 -3.8%
H
58.2
66.1
|
L
 -27.2%
H
56.0
86.1
|
L
 -10.5%
H
47.3
87.3
|
L
 -23.8%
H
47.3
98.0
|
L
 -48.8%
H
43.5
119.9
|
L
 72.6%
H
26.0
142.1
|
| Herbalife Nutrition Ltd |
|
1,526.7
|
14.8
|
L
 -0.8%
H
14.8
15.1
|
L
 -3.0%
H
14.6
15.8
|
L
 -24.5%
H
14.4
20.4
|
L
 5.6%
H
12.6
20.4
|
L
 88.4%
H
6.2
20.4
|
L
 -13.2%
H
5.0
20.4
|
L
 -67.7%
H
5.0
55.8
|
L
 -51.7%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
1,625.9
|
56.9
|
L
 4.0%
H
54.6
57.1
|
L
 -2.4%
H
54.6
61.3
|
L
 -4.9%
H
54.6
86
|
L
 -41.1%
H
53.1
102.6
|
L
 -65.0%
H
53.1
173.0
|
L
 -77.0%
H
53.1
330
|
L
 -72.2%
H
53.1
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
2,896.8
|
84.2
|
L
 -0.2%
H
83.9
84.8
|
L
 1.1%
H
82.0
87.3
|
L
 1.4%
H
82.0
90
|
L
 7.1%
H
76.2
100.1
|
L
 -30.2%
H
62
127.6
|
L
 15.4%
H
62
146.4
|
L
 -5.1%
H
50.1
146.4
|
L
 149.7%
H
18.1
146.4
|
| McKesson |
|
107,994.7
|
881.7
|
L
 -1.9%
H
877.3
904.0
|
L
 -6.6%
H
877.3
960.0
|
L
 -5.9%
H
877.3
999
|
L
 7.5%
H
794.6
999
|
L
 32.8%
H
637
999
|
L
 159.8%
H
334.8
999
|
L
 364.6%
H
180.4
999
|
L
 456.9%
H
106.1
999
|
| Medtronic |
|
111,364.2
|
86.7
|
L
 -0.2%
H
86.3
87.3
|
L
 -0.7%
H
86.3
89.4
|
L
 -11.1%
H
86.3
99.0
|
L
 -12.1%
H
86.3
105.5
|
L
 -5.6%
H
79.6
106.3
|
L
 10.8%
H
68.9
106.3
|
L
 -25.6%
H
68.9
135.9
|
L
 13.7%
H
68.9
135.9
|
| Mettler-Toledo International |
|
24,547.0
|
1,207.7
|
L
 1.5%
H
1204.2
1215.8
|
L
 3.4%
H
1162.8
1238.3
|
L
 -12.3%
H
1162.8
1411.6
|
L
 -13.9%
H
1162.8
1514.4
|
L
 -1.0%
H
946.7
1525.2
|
L
 -17.0%
H
928.5
1616.0
|
L
 7.5%
H
928.5
1714.8
|
L
 260.6%
H
332.0
1714.8
|
| Envista Holdings Corp |
|
4,113.3
|
25.1
|
L
 -0.6%
H
25.0
25.5
|
L
 -1.3%
H
24.2
26.1
|
L
 -12.6%
H
24.2
29.9
|
L
 12.7%
H
21.6
30.4
|
L
 47.7%
H
14.2
30.4
|
L
 -33.2%
H
14.2
40.9
|
L
 -39.4%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
144.5
|
1.9
|
L
 -6.9%
H
1.9
2.1
|
L
 -19.9%
H
1.9
2.6
|
L
 -23.8%
H
1.9
2.7
|
L
 -33.5%
H
1.8
3.0
|
L
 -81.3%
H
1.8
10.1
|
L
 -85.1%
H
1.8
28.4
|
L
 -95.1%
H
1.8
49.2
|
L
 -95.2%
H
1.8
49.2
|
| Penumbra Inc |
|
13,243.0
|
337.5
|
L
 0.0%
H
336.1
337.7
|
L
 0.7%
H
334.9
339.0
|
L
 -1.0%
H
333.9
344.5
|
L
 6.8%
H
290
362.4
|
L
 20.8%
H
221.3
362.4
|
L
 28.3%
H
148
362.4
|
L
 26.5%
H
114.9
362.4
|
L
 617.1%
H
43.7
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
25,209.2
|
26.5
|
L
 -1.3%
H
26.5
26.8
|
L
 -6.2%
H
26.5
28.7
|
L
 -14.4%
H
26.5
32.2
|
L
 -0.6%
H
26.5
33.4
|
L
 -1.1%
H
21.5
33.4
|
L
 61.5%
H
15.6
33.4
|
L
 -53.6%
H
11.8
61.2
|
L
 -2.9%
H
11.8
61.2
|
| Qiagen NV |
|
8,224.5
|
39.9
|
L
 -1.8%
H
39.8
40.4
|
L
 -2.9%
H
39.8
42.1
|
L
 -17.4%
H
39.8
49.9
|
L
 -16.8%
H
39.8
57.8
|
L
 -4.4%
H
39.8
57.8
|
L
 -22.5%
H
38.8
57.8
|
L
 -28.3%
H
38.8
64.7
|
L
 57.9%
H
23.1
65.9
|
| ResMed |
|
32,910.2
|
225.9
|
L
 -0.7%
H
225
227.5
|
L
 -2.8%
H
225
235.8
|
L
 -11.9%
H
225
261.9
|
L
 -7.8%
H
225
277.7
|
L
 1.7%
H
199.9
293.8
|
L
 9.1%
H
132.2
293.8
|
L
 21.7%
H
132.2
301.3
|
L
 301.0%
H
55.1
301.3
|
| Steris PLC |
|
21,365.6
|
217.9
|
L
 0.0%
H
216.0
218.5
|
L
 2.6%
H
210.0
223.0
|
L
 -13.3%
H
210.0
255.7
|
L
 -14.4%
H
210.0
269.4
|
L
 -3.3%
H
204.9
269.4
|
L
 23.4%
H
176.1
269.4
|
L
 16.3%
H
159.2
269.4
|
L
 222.7%
H
63.3
269.4
|
| Stevanato Grp Spa |
|
4,174.2
|
15.3
|
L
 0.8%
H
15.0
15.6
|
L
 4.4%
H
14.8
15.7
|
L
 -6.2%
H
14.1
17.6
|
L
 -25.5%
H
13.9
22
|
L
 -29.2%
H
13.9
28
|
L
 -33.9%
H
13.9
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
| Stryker |
|
129,452.1
|
338.3
|
L
 -0.4%
H
337.7
342.3
|
L
 0.3%
H
335.7
355.8
|
L
 -9.2%
H
328.2
389.3
|
L
 -4.8%
H
328.2
389.3
|
L
 -10.5%
H
328.2
404.9
|
L
 23.3%
H
250.0
406.2
|
L
 47.1%
H
188.8
406.2
|
L
 222.3%
H
104.0
406.2
|
| Smith & Nephew PLC (ADR) |
|
-
|
32.1
|
L
 -0.7%
H
32.1
32.4
|
L
 -2.8%
H
32.1
33.5
|
L
 -10.0%
H
32.1
37.1
|
L
 -2.1%
H
31.9
37.1
|
L
 13.1%
H
23.9
38.8
|
L
 13.4%
H
21.5
38.8
|
L
 -15.3%
H
21.5
44.5
|
L
 -2.1%
H
21.5
52.3
|
| Teleflex Incorporated |
|
4,689.2
|
106.1
|
L
 -0.9%
H
106.1
107.7
|
L
 -2%
H
106.0
111.6
|
L
 -5.1%
H
106.0
123.7
|
L
 -13.0%
H
100.2
127.5
|
L
 -23.8%
H
100.2
143.3
|
L
 -55.0%
H
100.2
276.4
|
L
 -73.5%
H
100.2
449.4
|
L
 -29.1%
H
100.2
449.4
|
| Thermo Fisher |
|
174,917.1
|
470.9
|
L
 0.1%
H
469.1
474.8
|
L
 -1.0%
H
458.3
481.6
|
L
 -8.6%
H
458.3
521.6
|
L
 -17.1%
H
458.3
644.0
|
L
 -9.2%
H
385.5
644.0
|
L
 -14.0%
H
385.5
644.0
|
L
 5.8%
H
385.5
672.3
|
L
 236.3%
H
137.4
672.3
|
| Waters |
|
29,433.5
|
300.0
|
L
 0.2%
H
298.2
303.4
|
L
 5.9%
H
282.8
303.4
|
L
 -8.7%
H
282.8
335.7
|
L
 -20.6%
H
282.8
408.7
|
L
 -19.2%
H
275.1
414.2
|
L
 0.4%
H
231.9
423.6
|
L
 11.7%
H
231.9
428.2
|
L
 130.9%
H
128.8
428.2
|
| West Pharma Services |
|
17,265.7
|
239.5
|
L
 -0.3%
H
238.2
240.8
|
L
 3.7%
H
231.4
244.3
|
L
 -1.8%
H
228.4
254.6
|
L
 -12.1%
H
223.8
291.4
|
L
 4.0%
H
187.4
322.3
|
L
 -27.4%
H
187.4
415.7
|
L
 -13.6%
H
187.4
475.4
|
L
 265.8%
H
64.8
475.4
|
| Zimmer Biomet Holdings |
|
17,520.6
|
89.6
|
L
 -0.3%
H
89.3
90.2
|
L
 -3.3%
H
88.6
95.3
|
L
 -9.8%
H
88.6
101.5
|
L
 0.5%
H
84.6
101.5
|
L
 -20.7%
H
84.6
114.4
|
L
 -28.0%
H
84.6
149.3
|
L
 -40.6%
H
84.6
169.7
|
L
 -9.0%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
7,731.3
|
268.6
|
L
H
268.6
268.6
|
L
H
268.6
268.6
|
L
 2.6%
H
267.6
282.0
|
L
 -13.6%
H
257.1
312.8
|
L
 1.0%
H
225.3
321.1
|
L
 -19.2%
H
225.3
373.4
|
L
 -19.2%
H
225.3
373.4
|
L
 -19.2%
H
225.3
373.4
|
| Haleon PLC (ADR) |
|
45,191.1
|
10.2
|
L
 -0.8%
H
10.2
10.3
|
L
 0.8%
H
10.0
10.6
|
L
 -8.6%
H
10.0
11.3
|
L
 2.5%
H
9.7
11.3
|
L
 -2.1%
H
8.7
11.4
|
L
 28.8%
H
7.7
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
9,585.7
|
85.7
|
L
 0.0%
H
85.2
86.3
|
L
 1.2%
H
83.5
89.8
|
L
 -14.2%
H
83.5
101.4
|
L
 -10.9%
H
83.5
118.3
|
L
 -22%
H
81.4
118.3
|
L
 -30.0%
H
79.5
139.0
|
L
 -33.2%
H
79.5
203.2
|
L
 75.2%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
2.9
|
2.2
|
L
 0.5%
H
2.2
2.2
|
L
 28.3%
H
1.8
2.2
|
L
 8.8%
H
1.4
2.2
|
L
 -22.4%
H
1.4
3.4
|
L
 -93.1%
H
1.4
35.2
|
L
 -99.3%
H
1.4
576
|
L
 -99.9%
H
1.4
9992
|
L
 -100.0%
H
1.4
109078.8
|
| Ainos Inc |
|
10.3
|
1.5
|
L
 1.4%
H
1.5
1.5
|
L
 0.7%
H
1.4
1.6
|
L
 14.0%
H
1.3
1.8
|
L
 -30.3%
H
1.3
2.5
|
L
 -41.7%
H
1.3
4.5
|
L
 -96.1%
H
1.3
36
|
L
 -99.3%
H
1.3
1781.3
|
L
 286.8%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
183.6
|
2.9
|
L
 8.1%
H
2.6
3.0
|
L
 34.9%
H
1.8
3.3
|
L
 57.2%
H
1.5
3.3
|
L
 34.3%
H
1.5
3.3
|
L
 -1.7%
H
1.5
12
|
L
 -37.8%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,461.5
|
174.8
|
L
 -0.8%
H
174.8
178.7
|
L
 4.7%
H
162.3
180.6
|
L
 -7.7%
H
162.3
192.7
|
L
 10.9%
H
154.6
199.1
|
L
 5.2%
H
122
208.3
|
L
 -45.5%
H
122
413.2
|
L
 -67.0%
H
122
737.5
|
L
 153.7%
H
68.4
737.5
|
| Angiodynamic Inc |
|
427.0
|
10.4
|
L
 -2.5%
H
10.3
10.6
|
L
 -3.3%
H
10.3
10.9
|
L
 -7.5%
H
10.3
11.7
|
L
 -22.5%
H
9.7
13.9
|
L
 10.2%
H
8.4
14.0
|
L
 -15.9%
H
5.3
14.0
|
L
 -51.4%
H
5.3
32
|
L
 -9.0%
H
5.3
32
|
| Anika Therapeutics Inc |
|
191.8
|
14.3
|
L
 0.9%
H
14.1
14.6
|
L
 0.1%
H
13.9
14.8
|
L
 33.7%
H
10.5
15.1
|
L
 49.5%
H
9.0
15.1
|
L
 -10.3%
H
7.9
15.9
|
L
 -46.7%
H
7.9
29.3
|
L
 -60.7%
H
7.9
48.4
|
L
 -67.3%
H
7.9
75.7
|
| Apyx Medical Corp |
|
143.9
|
3.4
|
L
 -2.6%
H
3.4
3.5
|
L
 -5.0%
H
3.4
4.0
|
L
 -8.3%
H
3.0
4.1
|
L
 -1.4%
H
3.0
4.5
|
L
 215.6%
H
0.8
4.5
|
L
 18.2%
H
0.8
8.0
|
L
 -67.6%
H
0.8
17.5
|
L
 102.4%
H
0.8
17.5
|
| Accuray Inc |
|
47.5
|
0.4
|
L
 -7.0%
H
0.4
0.4
|
L
 -4.8%
H
0.3
0.5
|
L
 -27.3%
H
0.3
0.6
|
L
 -56.0%
H
0.3
0.9
|
L
 -78.6%
H
0.3
2.1
|
L
 -85.7%
H
0.3
4.3
|
L
 -92.3%
H
0.3
5.9
|
L
 -92.6%
H
0.3
6.4
|
| Alphatec Holdings Inc |
|
1,899.5
|
12.6
|
L
 -1.3%
H
12.5
12.8
|
L
 0.4%
H
12.2
13.1
|
L
 -6.9%
H
11.9
14.4
|
L
 -37.3%
H
11.9
23.3
|
L
 31.6%
H
8.8
23.3
|
L
 -18.0%
H
4.9
23.3
|
L
 -31.4%
H
4.9
23.3
|
L
 354.7%
H
1.2
23.3
|
| Atricure Inc |
|
1,423.1
|
28.6
|
L
 -1.6%
H
28.4
29.3
|
L
 -3.3%
H
28.4
31.1
|
L
 -11.8%
H
28.4
33.5
|
L
 -30.2%
H
28.4
43.2
|
L
 -18.0%
H
28.3
43.2
|
L
 -27.1%
H
18.9
59.6
|
L
 -54.3%
H
18.9
89.2
|
L
 66.6%
H
13.4
89.2
|
| Axogen Inc |
|
1,608.3
|
31.0
|
L
 -0.6%
H
30.9
31.5
|
L
 -2.4%
H
30.1
34.2
|
L
 -11.5%
H
27.5
35.9
|
L
 -3.1%
H
27.5
36
|
L
 73.1%
H
9.2
36
|
L
 277.0%
H
3.5
36
|
L
 44.3%
H
3.5
36
|
L
 484.7%
H
3.5
56.9
|
| Bone Biologics Corp |
|
2.2
|
1.2
|
L
 4.3%
H
1.2
1.2
|
L
 -4.0%
H
1.2
1.3
|
L
 0.8%
H
1.1
1.4
|
L
 -33.9%
H
1.1
2.4
|
L
 -75.4%
H
1.1
6.8
|
L
 -99.7%
H
1.1
520.9
|
L
 -100.0%
H
1.1
10255.5
|
L
H
1.1
169920
|
| BioAffinity Tech Inc |
|
14.4
|
3.2
|
L
 7.7%
H
3.1
3.6
|
L
 199.1%
H
1.6
3.6
|
L
 171.2%
H
0.9
3.6
|
L
 158.1%
H
0.7
3.6
|
L
 -62.8%
H
0.7
46.5
|
L
 -93.7%
H
0.7
108.6
|
L
H
0.7
466.5
|
L
H
0.7
466.5
|
| Bluejay Diagnostics Inc |
|
1.9
|
2.0
|
L
H
1.8
2.0
|
L
 -1.5%
H
1.8
2.0
|
L
 -2.0%
H
1.7
2.3
|
L
 -39.1%
H
1.7
4
|
L
 -88.1%
H
1.7
40.8
|
L
 -100.0%
H
1.7
22368
|
L
H
1.7
200000
|
L
H
1.7
200000
|
| Biolife Soln Inc |
|
924.5
|
19.1
|
L
 -2%
H
19.0
19.5
|
L
 5.5%
H
17.9
19.8
|
L
 -17.6%
H
17.9
25.3
|
L
 -23.7%
H
17.9
26.7
|
L
 -24.9%
H
17.9
29.6
|
L
 -11.1%
H
8.9
29.6
|
L
 -50.6%
H
8.9
60.7
|
L
 951.6%
H
1.4
60.7
|
| Biomerica Inc |
|
6.2
|
2.1
|
L
 -1.0%
H
2
2.2
|
L
 4.6%
H
2.0
2.2
|
L
 -7.2%
H
1.9
2.2
|
L
 -10.8%
H
1.9
2.9
|
L
 202.9%
H
0.4
4.9
|
L
 -8.8%
H
0.2
4.9
|
L
 -69.5%
H
0.2
7.4
|
L
 71.7%
H
0.2
23.4
|
| Bruker Corp |
|
5,145.0
|
33.8
|
L
 0.5%
H
33.3
34.1
|
L
 -3.6%
H
32.4
35.9
|
L
 -12.8%
H
32.4
41.5
|
L
 -27.3%
H
32.4
56.2
|
L
 -27.6%
H
28.5
56.2
|
L
 -53.2%
H
28.5
94.9
|
L
 -44.3%
H
28.5
94.9
|
L
 24.2%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
5.8
|
0.3
|
L
 3.9%
H
0.3
0.3
|
L
 -12.9%
H
0.2
0.3
|
L
H
0.2
0.3
|
L
 -76.5%
H
0.2
1.3
|
L
 -83.6%
H
0.2
2.1
|
L
 -90.8%
H
0.2
7.1
|
L
 -99.5%
H
0.2
66
|
L
 -100.0%
H
0.2
20040
|
| Biosig Tech Inc |
|
153.7
|
1.7
|
L
 -1.8%
H
1.7
1.8
|
L
 -13.4%
H
1.6
2.1
|
L
 -27.0%
H
1.6
2.5
|
L
 -55.7%
H
1.6
4.0
|
L
 158.5%
H
0.4
14.1
|
L
 97.6%
H
0.1
14.1
|
L
 -63.6%
H
0.1
14.1
|
L
 -49.4%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
573.3
|
8.5
|
L
 -5.4%
H
8.5
9.0
|
L
 -1.1%
H
8.5
9.2
|
L
 -0.8%
H
8.1
9.5
|
L
 13.6%
H
7.1
9.5
|
L
 -14.3%
H
5.8
10.1
|
L
 554.6%
H
0.8
14.4
|
L
 -43.0%
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
536.8
|
13.7
|
L
 -1.9%
H
13.6
14.1
|
L
 -0.5%
H
13.3
14.4
|
L
 128.6%
H
5.6
14.7
|
L
 219.4%
H
4.5
14.7
|
L
 442.5%
H
2.0
14.7
|
L
 2634%
H
0.3
14.7
|
L
 544.8%
H
0.3
14.7
|
L
H
0.3
14.7
|
| Cardio Diagnostics Holdings Inc |
|
4.7
|
2.6
|
L
 4.1%
H
2.5
2.7
|
L
 -43.9%
H
2.2
4.4
|
L
 14.3%
H
2.2
7.9
|
L
 -20.7%
H
1.0
7.9
|
L
 -81.6%
H
1.0
17.4
|
L
 -97.9%
H
1.0
164.7
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
902.4
|
17.6
|
L
 0.2%
H
17.4
17.8
|
L
 7.1%
H
16.5
17.8
|
L
 -11.3%
H
16.3
19.7
|
L
 -9.4%
H
16.3
21.5
|
L
 -8.1%
H
11.0
21.5
|
L
 89.9%
H
4.8
34.8
|
L
 -74.4%
H
4.8
96.9
|
L
 294.2%
H
0.8
99.8
|
| Celcuity Inc |
|
5,020.4
|
108.5
|
L
 -4.0%
H
108.5
112.2
|
L
 -2.1%
H
107.1
119.3
|
L
 1.6%
H
102.9
119.7
|
L
 7.3%
H
97.5
120.3
|
L
 930.4%
H
7.6
120.3
|
L
 955.4%
H
7.6
120.3
|
L
 598.6%
H
4.8
120.3
|
L
H
4.0
120.3
|
| Creative Medical Tech Holdings Inc |
|
6.6
|
1.9
|
L
H
1.9
1.9
|
L
 -3.1%
H
1.9
2.0
|
L
 -3.1%
H
1.8
2.0
|
L
 -10.9%
H
1.5
2.5
|
L
 -38.0%
H
1.5
6.3
|
L
 -60.8%
H
1.5
13.3
|
L
 -99.1%
H
1.5
309.5
|
L
 -100.0%
H
1.5
525000
|
| Cerus Corp |
|
332.5
|
1.7
|
L
 -1.7%
H
1.7
1.8
|
L
 1.8%
H
1.6
1.9
|
L
 -32.4%
H
1.6
2.7
|
L
 -17.2%
H
1.6
3.0
|
L
 13.1%
H
1.1
3.0
|
L
 -41.0%
H
1.1
3.1
|
L
 -71.7%
H
1.1
8.1
|
L
 -70.9%
H
1.1
8.9
|
| Check-Cap Ltd |
|
12.0
|
1.6
|
L
 -1.8%
H
1.6
1.6
|
L
 -0.6%
H
1.6
1.8
|
L
 -5.8%
H
1.4
2
|
L
 -12.8%
H
1.3
3.9
|
L
 124.7%
H
0.6
3.9
|
L
 -43.6%
H
0.6
4.6
|
L
 -96.2%
H
0.6
43.8
|
L
 -99.8%
H
0.6
173376
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
7.6
|
0.6
|
L
 -3.3%
H
0.6
0.6
|
L
H
0.6
0.6
|
L
 -4.8%
H
0.5
0.7
|
L
 -61.2%
H
0.5
2.0
|
L
 -80.9%
H
0.5
5.0
|
L
 -92.8%
H
0.5
8.9
|
L
 -95.4%
H
0.5
23.5
|
L
 -97.5%
H
0.5
24.3
|
| ClearPoint Neuro Inc |
|
270.4
|
9.1
|
L
 -1.0%
H
9.0
9.2
|
L
 -21.2%
H
9
11.9
|
L
 -36.7%
H
8.6
15.3
|
L
 -36.0%
H
8.6
16.6
|
L
 -32.1%
H
8.6
30.1
|
L
 20.6%
H
4.1
30.1
|
L
 -54.6%
H
4.1
30.1
|
L
 -25.5%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
125.8
|
1.8
|
L
 1.1%
H
1.8
1.9
|
L
 -3.7%
H
1.7
2.0
|
L
 12.9%
H
1.5
2.1
|
L
 -28.4%
H
1.5
3.3
|
L
 -52.1%
H
1.5
4.6
|
L
 4.5%
H
0.9
6.4
|
L
 -84.0%
H
0.9
11.9
|
L
 -99.5%
H
0.7
480.2
|
| Castle Biosciences Inc |
|
749.2
|
25.2
|
L
 -2.0%
H
25.2
25.7
|
L
 -0.5%
H
25.1
26.8
|
L
 -19.6%
H
24.9
32.1
|
L
 -36.1%
H
24.9
44.3
|
L
 22.7%
H
14.6
44.3
|
L
 17.8%
H
9.3
44.3
|
L
 -62.1%
H
9.3
78.9
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
577.2
|
4.5
|
L
 -0.4%
H
4.5
4.6
|
L
 12.3%
H
4.0
4.6
|
L
 3.5%
H
4.0
4.6
|
L
 -9.3%
H
4.0
6.0
|
L
 6.4%
H
2.4
6.2
|
L
 -52.7%
H
2.4
12.3
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
38.3
|
0.6
|
L
 -4.7%
H
0.6
0.7
|
L
 -16.4%
H
0.6
0.7
|
L
 -6.2%
H
0.6
0.8
|
L
 -4.7%
H
0.6
0.8
|
L
 -46.0%
H
0.6
1.4
|
L
 -80.5%
H
0.6
4.3
|
L
 -93.3%
H
0.6
9.8
|
L
 -86.9%
H
0.6
15.0
|
| Citius Pharma Inc |
|
17.7
|
0.8
|
L
 -2.5%
H
0.8
0.8
|
L
 -9.2%
H
0.8
1.0
|
L
 14.5%
H
0.7
1.1
|
L
 -26.2%
H
0.6
1.2
|
L
 -50.9%
H
0.6
2.5
|
L
 -96.9%
H
0.1
42.8
|
L
 -98.4%
H
0.1
114
|
L
 -99.9%
H
0.1
843.8
|
| CVRx Inc |
|
217.6
|
8.3
|
L
 -4.2%
H
8.3
8.7
|
L
 11.2%
H
7.1
9.0
|
L
 56.6%
H
5.2
9.0
|
L
 3.0%
H
4.4
9.0
|
L
 -32.1%
H
4.3
13.3
|
L
 -16.3%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
319.0
|
9.2
|
L
 -1.7%
H
9.1
9.3
|
L
 -3.2%
H
9.1
10.0
|
L
 -3.7%
H
8.5
10.2
|
L
 -8.8%
H
8.5
11.2
|
L
 -32.4%
H
8.1
18.2
|
L
 108.6%
H
2.3
18.2
|
L
 -49.9%
H
2.3
19.6
|
L
 -100.0%
H
2.3
838880000
|
| Alpha Tau Medical Ltd |
|
632.8
|
7.2
|
L
 -1.8%
H
7.2
7.4
|
L
 3.2%
H
7.0
7.7
|
L
 -0.7%
H
6.1
8.6
|
L
 41.8%
H
4.8
8.6
|
L
 176.5%
H
2.3
8.6
|
L
 139.7%
H
1.8
8.6
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
25,762.9
|
66.9
|
L
 -0.5%
H
66.7
67.7
|
L
 2.6%
H
63.8
68.8
|
L
 -7.4%
H
63.8
74.5
|
L
 1.3%
H
62.9
76.0
|
L
 -8.8%
H
54.1
90.0
|
L
 -41.2%
H
54.1
142
|
L
 -22.3%
H
54.1
164.9
|
L
 341.0%
H
10.7
164.9
|
| Daxor Corp |
|
64.8
|
11.1
|
L
H
11.1
11.4
|
L
 -3.3%
H
11.1
11.8
|
L
 -9.7%
H
11.1
12.4
|
L
 -13.8%
H
11.1
14.8
|
L
 34.5%
H
7.1
14.8
|
L
 15.0%
H
6.6
14.8
|
L
 -9.1%
H
6.6
15.5
|
L
 38.1%
H
3.4
24.1
|
| ElectroCore Inc |
|
50.6
|
6.3
|
L
 -3.5%
H
6.0
6.4
|
L
H
6.0
7.3
|
L
 2.6%
H
5.8
8.2
|
L
 37.6%
H
4.4
8.3
|
L
 -21.0%
H
4.2
8.6
|
L
 92.4%
H
3.1
19.5
|
L
 -81.2%
H
2.9
36.7
|
L
H
2.9
303.8
|
| Ekso Bionics Holdings Inc |
|
37.0
|
10.4
|
L
 -0.2%
H
10.3
10.4
|
L
 -12.1%
H
10.2
12.7
|
L
 -15.6%
H
9.6
13.5
|
L
 113.6%
H
4.8
13.5
|
L
 -89.7%
H
2.7
146.3
|
L
 -96.6%
H
2.7
704.0
|
L
 -99.3%
H
2.7
1613.3
|
L
 -99.9%
H
2.7
24232.5
|
| Embecta Corp |
|
535.3
|
9.0
|
L
 -0.9%
H
8.9
9.3
|
L
 2.6%
H
8.7
9.5
|
L
 -14.2%
H
8.7
10.9
|
L
 -23.1%
H
8.7
13.4
|
L
 -33.7%
H
8.7
15.6
|
L
 -69.7%
H
8.7
32
|
L
H
8.7
63
|
L
H
8.7
63
|
| Establishment Labs Holdings Inc |
|
1,876.2
|
64.0
|
L
 -2.4%
H
63.7
66.1
|
L
 0.6%
H
61.6
66.6
|
L
 -15.7%
H
61.6
83.3
|
L
 -14.0%
H
61.6
83.3
|
L
 60.7%
H
26.6
83.3
|
L
 -8.0%
H
17
83.3
|
L
 5.6%
H
17
93.8
|
L
H
7.6
93.8
|
| Exact Sciences Corp |
|
20,035.6
|
105.0
|
L
 1%
H
104.9
105.0
|
L
 1.6%
H
103.5
105.0
|
L
 1.6%
H
103.0
105.0
|
L
 3.1%
H
101.4
105.0
|
L
 129.7%
H
38.8
105.0
|
L
 65.4%
H
38.8
105.0
|
L
 -21.5%
H
29.3
140.2
|
L
 1571.3%
H
5.4
159.5
|
| EDAP TMS S.A. (ADR) |
|
141.3
|
3.8
|
L
 -0.5%
H
3.8
3.9
|
L
 -6.0%
H
3.8
4.2
|
L
 -19.8%
H
3.5
4.9
|
L
 28.6%
H
2.7
5.1
|
L
 58.8%
H
1.2
5.1
|
L
 -65.1%
H
1.2
12.2
|
L
 -54.1%
H
1.2
12.7
|
L
 -12.3%
H
1.2
12.7
|
| GlucoTrack Inc |
|
1.1
|
1.1
|
L
 -4.6%
H
1.1
1.1
|
L
 -17.3%
H
1.1
1.3
|
L
 -35.2%
H
1.1
1.7
|
L
 -77.9%
H
1.1
4.8
|
L
 -95.5%
H
1.1
30.5
|
L
 -100.0%
H
1.1
22500
|
L
 -100.0%
H
1.1
46800
|
L
 -100.0%
H
1.1
468000
|
| GE HealthCare Tech |
|
31,875.1
|
69.9
|
L
 -0.6%
H
69.7
70.6
|
L
 -0.6%
H
69.4
73.9
|
L
 -15.8%
H
69.2
87.1
|
L
 -15.6%
H
69.2
89.8
|
L
 -15.1%
H
57.7
89.8
|
L
 -7.8%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
239.5
|
5.4
|
L
 -3.2%
H
5.1
5.5
|
L
 9.7%
H
4.5
5.8
|
L
 -7.5%
H
4
6.5
|
L
 -28.1%
H
4
8
|
L
 -21.3%
H
2.8
9.5
|
L
 -82.0%
H
2.8
62.9
|
L
 -91.1%
H
2.8
87.5
|
L
 -80.4%
H
2.8
87.5
|
| Hologic |
|
16,837.1
|
75.4
|
L
 0.1%
H
75.4
75.4
|
L
 0.3%
H
75
75.4
|
L
 0.4%
H
75
75.8
|
L
 0.6%
H
74.2
75.8
|
L
 22.7%
H
51.9
75.8
|
L
 -2.1%
H
51.9
87.9
|
L
 4.7%
H
51.9
87.9
|
L
 118.7%
H
26.5
87.9
|
| Heart Test Laboratories Inc |
|
8.2
|
2.6
|
L
H
2.6
2.6
|
L
 1.2%
H
2.6
2.8
|
L
 -12.6%
H
2.5
3.0
|
L
 8.9%
H
2.3
3.7
|
L
 -15.2%
H
2.0
6.5
|
L
 -97.7%
H
2.0
149
|
L
H
2.0
600
|
L
H
2.0
600
|
| Helius Medical Tech Inc (Class A) |
|
110.9
|
2.1
|
L
 -0.5%
H
2
2.1
|
L
 0.5%
H
2.0
2.3
|
L
 7.1%
H
1.7
2.4
|
L
 -29.5%
H
1.7
3.7
|
L
 -99.3%
H
1.7
366.8
|
L
 -100.0%
H
1.7
10836.4
|
L
 -100.0%
H
1.7
786750
|
L
 -100.0%
H
1.7
27168750
|
| Henry Schein |
|
8,277.0
|
72.2
|
L
 -0.7%
H
71.8
72.6
|
L
 -3.8%
H
71.2
76.5
|
L
 -6.0%
H
71.2
89.3
|
L
 -6.7%
H
71.2
89.3
|
L
 1.9%
H
60.6
89.3
|
L
 -6.6%
H
60.0
89.3
|
L
 8.0%
H
60.0
92.7
|
L
 9.8%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
116.6
|
1.2
|
L
 -0.8%
H
1.2
1.3
|
L
 2.6%
H
1.1
1.4
|
L
 3.5%
H
1.0
1.4
|
L
 9.1%
H
0.9
1.4
|
L
 41.2%
H
0.5
2.2
|
L
 -10.4%
H
0.5
3.3
|
L
 -87.9%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
697.5
|
9.0
|
L
 0.6%
H
8.7
9.0
|
L
 -2.4%
H
8.7
9.5
|
L
 -25.7%
H
8.7
12.4
|
L
 -29.3%
H
8.7
14.1
|
L
 -60.8%
H
8.7
23.2
|
L
 -83.3%
H
8.7
59.3
|
L
 -86.6%
H
8.7
77.4
|
L
 -72.6%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
42.8
|
0.6
|
L
 -1.6%
H
0.6
0.6
|
L
 -10.1%
H
0.6
0.7
|
L
 6.9%
H
0.6
0.7
|
L
 -8.8%
H
0.5
0.7
|
L
 -58.1%
H
0.5
1.4
|
L
 -41.0%
H
0.5
1.7
|
L
 -76.5%
H
0.5
16
|
L
 -46.1%
H
0.2
16
|
| SeaStar Medical Holding Corp |
|
8.5
|
2.2
|
L
 -1.3%
H
2.2
2.3
|
L
 -15.2%
H
2.2
2.7
|
L
 -7.1%
H
2.2
2.9
|
L
 -90.9%
H
2.2
27.9
|
L
 -98.9%
H
2.2
257
|
L
 -100.0%
H
2.2
6250
|
L
 -100.0%
H
2.2
55000
|
L
H
2.2
55000
|
| ICU Medical Inc |
|
3,103.3
|
125.7
|
L
 -0.7%
H
124.4
127.5
|
L
 -2.4%
H
123.5
132.4
|
L
 -16.1%
H
123.5
159.9
|
L
 -13.4%
H
123.5
160.3
|
L
 -16.9%
H
107
160.3
|
L
 -20.2%
H
78.4
212.4
|
L
 -39.4%
H
78.4
282
|
L
 26.8%
H
78.4
321.7
|
| Idexx Laboratories |
|
45,752.0
|
574.6
|
L
 -0.9%
H
574
581.4
|
L
 0.6%
H
567.6
600.0
|
L
 -8.9%
H
567.6
666.1
|
L
 -18.0%
H
567.6
726.4
|
L
 36.1%
H
356.3
770.0
|
L
 21.9%
H
356.3
770.0
|
L
 18.5%
H
317.1
770.0
|
L
 661.6%
H
74.5
770.0
|
| Inspira Tech Oxy B.H.N. Ltd |
|
23.8
|
0.6
|
L
 -1.8%
H
0.6
0.6
|
L
 -1.8%
H
0.6
0.6
|
L
 -5.2%
H
0.6
0.6
|
L
 -46.1%
H
0.6
1.1
|
L
 -21.4%
H
0.4
1.7
|
L
 -61.3%
H
0.4
2.5
|
L
H
0.4
9.6
|
L
H
0.4
9.6
|
| Intercure Ltd |
|
42.1
|
0.8
|
L
H
0.8
0.8
|
L
 -2.5%
H
0.7
0.8
|
L
 -8.3%
H
0.7
0.9
|
L
 -43.4%
H
0.7
1.3
|
L
 -50.3%
H
0.7
1.8
|
L
 -57.7%
H
0.7
3.7
|
L
 -89.5%
H
0.7
12.7
|
L
H
0.7
19.4
|
| Inogen Inc |
|
164.5
|
6.0
|
L
 -2.0%
H
6.0
6.2
|
L
 -1.0%
H
6
6.4
|
L
 3.6%
H
5.3
6.7
|
L
 -10.0%
H
5.3
7.5
|
L
 -19.3%
H
5.3
9.1
|
L
 -52.3%
H
4.1
14.1
|
L
 -88.1%
H
4.1
82.4
|
L
 -85.4%
H
4.1
287.8
|
| Inmode Ltd |
|
871.2
|
13.8
|
L
 -0.3%
H
13.7
13.8
|
L
 7.8%
H
13.3
13.9
|
L
 -8.9%
H
12.7
15.3
|
L
 -4.3%
H
12.7
16.7
|
L
 -26.0%
H
12.7
19.1
|
L
 -54.0%
H
12.7
48.3
|
L
 -61.3%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
4.9
|
0.7
|
L
 -1.4%
H
0.7
0.7
|
L
 -14.6%
H
0.7
1.0
|
L
 -27.1%
H
0.7
1.0
|
L
 -23.9%
H
0.7
4.6
|
L
 -98.7%
H
0.7
76.8
|
L
 -100.0%
H
0.7
4721.5
|
L
 -100.0%
H
0.7
32428.8
|
L
 -100.0%
H
0.7
141926.4
|
| IRIDEX Corp |
|
23.0
|
1.3
|
L
H
1.3
1.4
|
L
 0.8%
H
1.2
1.4
|
L
 -5.0%
H
1.2
1.5
|
L
 34%
H
1
1.7
|
L
 67.5%
H
0.8
1.7
|
L
 -34.6%
H
0.8
3.7
|
L
 -81.8%
H
0.8
9.7
|
L
 -87.1%
H
0.8
16.6
|
| Iradimed Corp |
|
1,267.6
|
99.2
|
L
 -0.7%
H
98.4
100.4
|
L
 -0.2%
H
98.3
103.7
|
L
 -1.7%
H
95.9
107
|
L
 2.0%
H
90.9
107.9
|
L
 87.6%
H
47.5
107.9
|
L
 162.6%
H
36.1
107.9
|
L
 323.1%
H
22.8
107.9
|
L
 431.7%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,763.0
|
116.4
|
L
 -1.1%
H
115.5
118.1
|
L
 1.5%
H
112.3
119.9
|
L
 -26.7%
H
112.3
164.7
|
L
 -33.2%
H
112.3
191.4
|
L
 12.9%
H
92.5
212
|
L
 3.1%
H
55.9
212
|
L
 -18.4%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
170,744.3
|
480.7
|
L
 0.2%
H
476.3
481.7
|
L
 0.3%
H
458
494.4
|
L
 -3.8%
H
458
511.9
|
L
 -16.0%
H
458
603.9
|
L
 -2.3%
H
425
603.9
|
L
 102.2%
H
237.6
616
|
L
 103.9%
H
180.1
616
|
L
 642.1%
H
64.0
616
|
| Jowell Global Ltd |
|
5.4
|
2.5
|
L
H
2.4
2.6
|
L
 0.4%
H
2.3
2.6
|
L
 28.7%
H
1.9
2.6
|
L
 5.1%
H
1.9
2.6
|
L
 2.1%
H
1.5
3.0
|
L
 -50.2%
H
1
9.1
|
L
 -97.9%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
98.0
|
34.2
|
L
 0.2%
H
34.2
34.2
|
L
 -4.0%
H
34.2
36.1
|
L
 -17.7%
H
34.2
43.4
|
L
 -10.7%
H
34.2
43.4
|
L
 -30.6%
H
30.3
60.9
|
L
 112.3%
H
14.6
71.3
|
L
 175.8%
H
11.4
71.3
|
L
 101.2%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
414.3
|
16.4
|
L
 -0.9%
H
16.4
16.7
|
L
 -6.6%
H
16.3
18.0
|
L
 -3.9%
H
15.7
20.2
|
L
 -4.0%
H
15.7
20.3
|
L
 -34.8%
H
15.3
26.4
|
L
 -61.5%
H
15.3
53.5
|
L
 -67.8%
H
15.3
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
194.6
|
4.2
|
L
 -2.3%
H
4.2
4.3
|
L
 -2.6%
H
4.1
4.5
|
L
 -10.5%
H
4.1
5.1
|
L
 -27.6%
H
4.1
6.6
|
L
 43.8%
H
1.9
6.6
|
L
 11.1%
H
1.9
6.6
|
L
 4.7%
H
1.8
6.6
|
L
 1172.7%
H
0.3
12.8
|
| Standard BioTools Inc |
|
370.6
|
1.0
|
L
 -1.0%
H
1.0
1.0
|
L
 2.2%
H
0.9
1
|
L
 -17.4%
H
0.9
1.3
|
L
 -41.7%
H
0.9
1.7
|
L
 -19.5%
H
0.9
1.7
|
L
 -54.8%
H
0.9
3.2
|
L
 -79.8%
H
0.9
7.5
|
L
 -87.4%
H
0.9
14.9
|
| LivaNova PLC |
|
3,440.0
|
62.9
|
L
 -1.0%
H
62.6
63.9
|
L
 6.1%
H
58.1
64.2
|
L
 -7.4%
H
58.1
71.9
|
L
 0.1%
H
58.1
71.9
|
L
 54.0%
H
32.5
71.9
|
L
 47.3%
H
32.5
71.9
|
L
 -17.8%
H
32.5
93.9
|
L
 16.1%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
2,403.1
|
105.5
|
L
 -3.2%
H
105.5
109.9
|
L
 -1.0%
H
105.5
113.3
|
L
 14.9%
H
88.3
115.3
|
L
 24.2%
H
79.4
115.3
|
L
 24.4%
H
71.4
115.3
|
L
 112.2%
H
44.3
115.3
|
L
 120.5%
H
38.3
115.3
|
L
 689.1%
H
13.1
115.3
|
| LENSAR Inc |
|
72.7
|
6.1
|
L
 -0.3%
H
6.0
6.2
|
L
 -47.9%
H
5.9
11.7
|
L
 -46.5%
H
5.9
12.2
|
L
 -49.3%
H
5.9
12.9
|
L
 -63.9%
H
5.9
16.9
|
L
 130.7%
H
1.8
17.3
|
L
 -26.4%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
4,943.6
|
76.5
|
L
 -1.9%
H
76.2
78.0
|
L
 -4.9%
H
76.2
81.5
|
L
 4.6%
H
72.3
84.4
|
L
 16.1%
H
63.4
84.4
|
L
 -25.9%
H
47.3
108.9
|
L
 -1.7%
H
47.3
126.9
|
L
 281.8%
H
19.3
126.9
|
L
 3804.1%
H
1.8
126.9
|
| Lucid Diagnostics Inc |
|
165.2
|
1.3
|
L
 -1.6%
H
1.3
1.3
|
L
 -9.4%
H
1.3
1.4
|
L
 -8.7%
H
1.3
1.5
|
L
 12.5%
H
1.0
1.6
|
L
 -16%
H
1.0
1.8
|
L
 -25%
H
0.6
1.9
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
57.9
|
1.4
|
L
 -1.4%
H
1.4
1.5
|
L
 -23.0%
H
1.4
1.9
|
L
 -3.5%
H
1.4
2.2
|
L
 -47.3%
H
1.4
2.6
|
L
 -82.4%
H
1.3
8.0
|
L
 -88.3%
H
1.3
14.8
|
L
 -97.4%
H
1.3
58.1
|
L
H
1.3
69.5
|
| Masimo Corp |
|
9,330.0
|
178.7
|
L
 0.0%
H
178.4
178.8
|
L
 1.8%
H
175.4
178.9
|
L
 1.9%
H
175.0
178.9
|
L
 33.3%
H
125.9
178.9
|
L
 3.5%
H
125.9
178.9
|
L
 4.1%
H
75.2
198
|
L
 -18.9%
H
75.2
305.2
|
L
 348.6%
H
39.2
305.2
|
| 908 Devices Inc |
|
224.3
|
6
|
L
 -1.5%
H
6.0
6.2
|
L
 -0.2%
H
5.8
6.4
|
L
 -14.2%
H
5.8
7.9
|
L
 2.7%
H
5.0
7.9
|
L
 42.9%
H
3.6
9.3
|
L
 -20.2%
H
1.8
12.5
|
L
 -88.3%
H
1.8
55.8
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
612.1
|
4.1
|
L
 -1.2%
H
4.1
4.3
|
L
 -5.9%
H
4.1
4.5
|
L
 -20.8%
H
4.1
5.5
|
L
 -41.6%
H
4.1
7.2
|
L
 -49.1%
H
4.1
8.1
|
L
 11.7%
H
3.1
10.1
|
L
 -59.4%
H
2.4
16.0
|
L
 -50.4%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
453.1
|
82.0
|
L
 -0.6%
H
81.6
83.2
|
L
 5.4%
H
76.9
83.3
|
L
 -10.9%
H
71.1
97.0
|
L
 1.2%
H
71.1
98.1
|
L
 -34.0%
H
55.5
131.2
|
L
 -50.4%
H
55.5
187.8
|
L
 -67.5%
H
55.5
333.4
|
L
 -9.9%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
4,006.9
|
67.4
|
L
 -1.3%
H
67.2
68.3
|
L
 -1.1%
H
67.2
71.7
|
L
 -17.6%
H
67.2
84.0
|
L
 -23.1%
H
67.2
94.8
|
L
 -33.6%
H
67.2
107.3
|
L
 -3.1%
H
62.6
111.5
|
L
 19.9%
H
50.5
111.5
|
L
 272.7%
H
17.1
111.5
|
| Modular Medical Inc |
|
26.6
|
0.2
|
L
H
0.2
0.2
|
L
 -13.6%
H
0.2
0.3
|
L
 -62.8%
H
0.1
0.5
|
L
 -44.1%
H
0.1
0.5
|
L
 -80%
H
0.1
1.3
|
L
 -90.1%
H
0.1
2.7
|
L
 -98.8%
H
0.1
19.5
|
L
 -76.5%
H
0.1
19.5
|
| Myriad Genetics Inc |
|
447.9
|
4.8
|
L
 0.8%
H
4.6
4.9
|
L
 -1.2%
H
4.4
5.1
|
L
 9.4%
H
4.1
5.7
|
L
 -26.9%
H
4.1
7.2
|
L
 -51.8%
H
3.8
10.3
|
L
 -79.2%
H
3.8
29.3
|
L
 -84.3%
H
3.8
37.0
|
L
 -87.3%
H
3.8
50.4
|
| MDxHealth SA (ADR) |
|
-
|
3.2
|
L
 -1.5%
H
3.2
3.3
|
L
 -1.2%
H
3.1
3.6
|
L
 -11.3%
H
3.1
3.8
|
L
 1.9%
H
3
4.3
|
L
 103.2%
H
1.4
5.3
|
L
 11.1%
H
1.4
5.3
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
| ENvue Medical Inc |
|
1.3
|
1.2
|
L
 -1.7%
H
1.2
1.2
|
L
 -36.7%
H
1.1
1.9
|
L
 -56.1%
H
1.1
3.0
|
L
 -60.3%
H
1.0
6.1
|
L
 -96.4%
H
0.7
162.5
|
L
 -99.7%
H
0.7
477.4
|
L
 -100.0%
H
0.7
9218
|
L
 -100.0%
H
0.7
18700
|
| ENDRA Life Sciences Inc |
|
3.8
|
3.2
|
L
 -0.9%
H
3.2
3.2
|
L
 -1.2%
H
3.2
3.5
|
L
 -15.5%
H
3.0
5.9
|
L
 -37.4%
H
3.0
5.9
|
L
 -18.2%
H
2.9
12.0
|
L
 -98.1%
H
0.0
182.5
|
L
 -99.9%
H
0.0
2857.7
|
L
H
0.0
5880
|
| Neogen Corp |
|
1,842.4
|
8.5
|
L
 -2.6%
H
8.5
8.7
|
L
 -9.4%
H
8.5
9.6
|
L
 -22.9%
H
8.5
11.4
|
L
 17.6%
H
6.9
11.4
|
L
 -8.0%
H
3.9
11.4
|
L
 -54.2%
H
3.9
24.1
|
L
 -79.5%
H
3.9
48.9
|
L
 -55.8%
H
3.9
48.9
|
| Nephros Inc |
|
-
|
2.9
|
L
 -1.7%
H
2.9
3.0
|
L
 -23.7%
H
2.8
3.8
|
L
 -25.5%
H
2.8
4.2
|
L
 -42.4%
H
2.8
5.5
|
L
 94.6%
H
1.5
6.4
|
L
 166.1%
H
1.0
6.4
|
L
 -61.4%
H
0.9
11.7
|
L
 -2.0%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
37.5
|
0.7
|
L
 2.8%
H
0.7
0.7
|
L
 -6.3%
H
0.7
0.8
|
L
 4.2%
H
0.6
0.9
|
L
 1.4%
H
0.6
1.0
|
L
 -26.7%
H
0.4
1.2
|
L
 -55.7%
H
0.4
2.1
|
L
 -91.5%
H
0.4
10
|
L
H
0.4
30
|
| Nano X Imaging Ltd |
|
173.3
|
2.5
|
L
 -0.8%
H
2.5
2.5
|
L
 -3.5%
H
2.4
2.7
|
L
 4.2%
H
2.3
2.8
|
L
 -16.7%
H
2.1
3.3
|
L
 -58.2%
H
2.1
6.2
|
L
 -62.8%
H
2.1
22.7
|
L
 -94.8%
H
2.1
64
|
L
H
2.1
94.8
|
| NeuroPace Inc |
|
431.6
|
12.8
|
L
 -2.4%
H
12.7
13.0
|
L
 -9.2%
H
12.7
14.7
|
L
 -11.5%
H
12.6
15.7
|
L
 -22.7%
H
12.6
17.9
|
L
 9.1%
H
7.6
19.0
|
L
 271.6%
H
3.4
19.0
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
78.4
|
1.9
|
L
 8.2%
H
1.7
1.9
|
L
 12.1%
H
1.6
2.0
|
L
 6.3%
H
1.6
2.0
|
L
 -7.0%
H
1.5
2.2
|
L
 -33.9%
H
1.5
2.9
|
L
 51.6%
H
1.0
3.9
|
L
 -84.7%
H
0.8
12.1
|
L
 -100.0%
H
0.8
405037.5
|
| Nortech Systems Inc |
|
27.4
|
9.8
|
L
H
9.3
9.8
|
L
 3.5%
H
9
9.8
|
L
 3.0%
H
8.5
9.8
|
L
 38.6%
H
7.1
9.8
|
L
 -0.6%
H
6.5
12.4
|
L
 -16.5%
H
6.5
19.2
|
L
 16.0%
H
5.5
19.6
|
L
 153.0%
H
1.7
19.6
|
| Natera Inc |
|
28,163.4
|
198.7
|
L
 -2.0%
H
198.0
201.3
|
L
 4.4%
H
187.0
204.3
|
L
 -8.2%
H
186.1
218.3
|
L
 -14.3%
H
186.1
256.4
|
L
 31.7%
H
125.4
256.4
|
L
 250.9%
H
36.9
256.4
|
L
 92.3%
H
26.1
256.4
|
L
 2155.5%
H
7.4
256.4
|
| Nutriband Inc |
|
47.7
|
3.9
|
L
 -0.8%
H
3.9
4.0
|
L
 2.9%
H
3.7
4.2
|
L
 -6.7%
H
3.6
4.5
|
L
 -12.7%
H
3.6
6.4
|
L
 -40.1%
H
3.6
11.7
|
L
 14.0%
H
1.5
11.8
|
L
 -79.2%
H
0.9
21.4
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
1.6
|
1.0
|
L
 -4.0%
H
1.0
1.1
|
L
 -24.2%
H
1.0
1.4
|
L
 -48.1%
H
1.0
1.9
|
L
 -55.1%
H
1.0
4.9
|
L
 -97.9%
H
1.0
50.8
|
L
 -100.0%
H
1.0
8423.1
|
L
 -100.0%
H
1.0
954030
|
L
 -100.0%
H
1.0
10000000000
|
| NovoCure Ltd |
|
1,353.0
|
11.9
|
L
 -2.1%
H
11.9
12.1
|
L
 -1%
H
11.8
12.8
|
L
 4.4%
H
10.8
15.5
|
L
 -7.4%
H
9.8
15.5
|
L
 -38.5%
H
9.8
20.1
|
L
 -79.2%
H
9.8
83.6
|
L
 -91.6%
H
9.8
232.8
|
L
 -4.5%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.9
|
12
|
L
 -2.4%
H
12
12.3
|
L
 9.0%
H
9.8
12.3
|
L
 20.1%
H
9.8
12.9
|
L
 7.1%
H
8.7
13.8
|
L
 -88.0%
H
8.7
196.7
|
L
 -93.2%
H
8.7
244.0
|
L
 -95.1%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
7.1
|
0.4
|
L
 -5%
H
0.4
0.4
|
L
 -7.3%
H
0.4
0.4
|
L
 -17.4%
H
0.4
0.7
|
L
 -54.2%
H
0.4
0.8
|
L
 -84.5%
H
0.4
2.6
|
L
 -64.8%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
134.5
|
3.1
|
L
 -0.3%
H
3.0
3.1
|
L
 -10.7%
H
3.0
3.5
|
L
 -33.9%
H
3.0
5.2
|
L
 -36.5%
H
3.0
5.4
|
L
 -72.1%
H
3.0
11.9
|
L
 -50.6%
H
3.0
20
|
L
H
3.0
37
|
L
H
3.0
37
|
| Nanobiotix (ADR) |
|
1,447.3
|
29.9
|
L
 -5.4%
H
29.7
30.4
|
L
 -5.1%
H
29.7
35.5
|
L
 13.8%
H
24.5
41.9
|
L
 35.2%
H
19.6
41.9
|
L
 687.1%
H
3.0
41.9
|
L
 767.0%
H
1.8
41.9
|
L
 93.0%
H
1.8
41.9
|
L
H
1.8
41.9
|
| Orchestra BioMed Holdings Inc |
|
281.3
|
4.5
|
L
 -2.2%
H
4.5
4.7
|
L
 3.7%
H
4.1
4.7
|
L
 14.1%
H
3.8
4.9
|
L
 4.4%
H
3.5
5
|
L
 2.5%
H
2.2
5.4
|
L
 -62.7%
H
2.2
23.4
|
L
 -59.8%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
459.7
|
11.5
|
L
 -2.1%
H
11.5
11.8
|
L
 -4.8%
H
11.5
12.3
|
L
 -16.9%
H
11.5
14.2
|
L
 -25.9%
H
11.5
16.4
|
L
 -31.6%
H
10.2
17
|
L
 -32.0%
H
9.6
21.6
|
L
 -75.0%
H
9.6
47.1
|
L
 -71.6%
H
9.6
74.4
|
| Outset Medical Inc |
|
61.3
|
3.4
|
L
 -0.6%
H
3.3
3.4
|
L
 6.0%
H
3.2
3.7
|
L
 -5.1%
H
3
3.7
|
L
 -9.5%
H
3
6.5
|
L
 -59.5%
H
3
22.0
|
L
 -98.9%
H
0.5
362.0
|
L
 -99.5%
H
0.5
915
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
306.2
|
2.4
|
L
 -0.8%
H
2.3
2.4
|
L
 -10.2%
H
2.3
2.7
|
L
 -40.2%
H
2.3
4.1
|
L
 -57.5%
H
2.3
5.9
|
L
 -53.1%
H
2.3
7.1
|
L
 19%
H
1.8
7.1
|
L
 -87.3%
H
1.8
24.3
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
197.7
|
2.9
|
L
 -1.7%
H
2.9
2.9
|
L
 -7.4%
H
2.8
3.5
|
L
 1.1%
H
2.5
3.5
|
L
 19.7%
H
2.3
3.5
|
L
 -18.5%
H
2.1
4.2
|
L
 -55.0%
H
2.1
8.5
|
L
 -74.8%
H
2.1
13.6
|
L
 -61.2%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
419.8
|
1.4
|
L
 -0.7%
H
1.4
1.4
|
L
 9.5%
H
1.3
1.4
|
L
 -17.3%
H
1.3
1.8
|
L
 -24.5%
H
1.3
2.7
|
L
 11.2%
H
0.9
2.7
|
L
 -83.3%
H
0.9
14.6
|
L
 -95.8%
H
0.9
37.4
|
L
 -83.4%
H
0.9
53.7
|
| PAVmed Inc |
|
8.8
|
9.5
|
L
 -1.9%
H
9.5
9.7
|
L
 -8.6%
H
9.5
10.5
|
L
 1.5%
H
8.7
11.0
|
L
 2.9%
H
6
28.4
|
L
 -57.7%
H
6
28.4
|
L
 -94.1%
H
6
280.8
|
L
 -99.5%
H
6
4365
|
L
H
6
6858
|
| Pro-Dex Inc (co) |
|
153.9
|
48
|
L
 -2.0%
H
47.9
49.5
|
L
 2.5%
H
46.7
51.8
|
L
 23.1%
H
38.3
51.8
|
L
 24.1%
H
36.6
51.8
|
L
 -3.7%
H
23.5
70.3
|
L
 174.3%
H
14.5
70.3
|
L
 92.1%
H
12.4
70.3
|
L
 1354.5%
H
3.1
70.3
|
| Pulse Biosciences Inc |
|
1,534.5
|
22.6
|
L
 0.8%
H
22.3
23.0
|
L
 6.0%
H
20.9
23.2
|
L
 -10.0%
H
17.5
24.4
|
L
 47.9%
H
13.2
26.3
|
L
 34.7%
H
12.6
26.3
|
L
 657.4%
H
2.4
26.3
|
L
 -4.3%
H
1.2
29.2
|
L
H
1.2
45.8
|
| Axe Compute Inc |
|
4.7
|
1.4
|
L
 -4.2%
H
1.3
1.4
|
L
 -22.5%
H
1.3
2.0
|
L
 -42.3%
H
1.3
2.8
|
L
 -79.7%
H
1.3
9
|
L
 -91.9%
H
1.3
39
|
L
 -98.6%
H
1.3
208.2
|
L
 -99.7%
H
1.3
492
|
L
 -100.0%
H
1.3
21750
|
| Precision Optics Corp Inc |
|
31.7
|
4.1
|
L
H
4.1
4.4
|
L
 -9.1%
H
4.0
4.8
|
L
 -8.5%
H
4.0
5.3
|
L
 0.7%
H
4.0
6.0
|
L
 -12.7%
H
3.8
6.0
|
L
 -30.1%
H
3.5
7.0
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
16,043.2
|
227.9
|
L
 -0.3%
H
226.5
228.0
|
L
 -3.5%
H
216.5
233.3
|
L
 -8.5%
H
216.5
253.3
|
L
 -21.3%
H
216.5
299.8
|
L
 -14.3%
H
216.5
354.9
|
L
 -26.3%
H
125.8
354.9
|
L
 -12.7%
H
125.8
354.9
|
L
 621.0%
H
26.5
354.9
|
| Procept BioRobotics Corp |
|
1,458.3
|
25.9
|
L
 0.7%
H
25.1
26.1
|
L
 -1%
H
24.8
28.7
|
L
 -3.4%
H
19.4
28.7
|
L
 -19.3%
H
19.4
35.4
|
L
 -55.3%
H
19.4
66.9
|
L
 -17.9%
H
19.4
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
351.2
|
20.9
|
L
 -1.3%
H
20.1
21.8
|
L
 0.4%
H
19.6
22.7
|
L
 8.1%
H
14.6
22.7
|
L
 19.4%
H
14.1
22.9
|
L
 392.2%
H
3.1
22.9
|
L
 75.1%
H
2.9
22.9
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
189.1
|
5.2
|
L
 1.0%
H
5.0
5.2
|
L
 -6.1%
H
5.0
6.1
|
L
 -25.4%
H
4.8
8.0
|
L
 -31.7%
H
4.8
9.0
|
L
 -24.4%
H
3.8
9.0
|
L
 -51.7%
H
3.8
15.5
|
L
 -77.4%
H
3.1
23.2
|
L
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
1,096.8
|
16.1
|
L
 -2.8%
H
16.0
16.6
|
L
 -10.1%
H
16.0
19.7
|
L
 -31.8%
H
16.0
24.3
|
L
 -44.4%
H
16.0
35.6
|
L
 -53.7%
H
16.0
39.0
|
L
 -81.1%
H
16.0
98.7
|
L
 -88.3%
H
16.0
180.1
|
L
 -5.2%
H
15.2
306.7
|
| Quanterix Corp |
|
205.6
|
4.4
|
L
 -0.7%
H
4.3
4.5
|
L
 -8.0%
H
4.3
4.9
|
L
 -26.4%
H
4.3
6.8
|
L
 -33.5%
H
4.3
8.8
|
L
 -39.2%
H
4.1
8.8
|
L
 -63.2%
H
4.1
29.7
|
L
 -92.6%
H
4.1
69.2
|
L
H
4.1
92.6
|
| AVITA Medical Inc |
|
122.2
|
4.0
|
L
 -1.0%
H
4.0
4.0
|
L
 -12.9%
H
3.9
4.8
|
L
 -8.9%
H
3.9
5.9
|
L
 15.3%
H
3.2
5.9
|
L
 -58.9%
H
3.2
10.3
|
L
 -70.2%
H
3.2
21.7
|
L
 -81.4%
H
3.2
22.5
|
L
 -52.8%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
38.6
|
1.0
|
L
 -4.9%
H
1.0
1.0
|
L
 8.9%
H
0.9
1.1
|
L
 -3.0%
H
0.9
1.1
|
L
 15.3%
H
0.8
1.3
|
L
 -44.3%
H
0.8
2.1
|
L
 -28.5%
H
0.8
6.2
|
L
 -93.4%
H
0.8
15.3
|
L
 -98.5%
H
0.8
116.4
|
| Vyome Holdings Inc |
|
13.0
|
2.3
|
L
 0.9%
H
2.2
2.3
|
L
 -3.0%
H
2.0
2.5
|
L
 -16.4%
H
2.0
3.5
|
L
 -37.5%
H
1.8
3.9
|
L
 265.1%
H
0.3
12.9
|
L
 -98.5%
H
0.3
237.8
|
L
 -100.0%
H
0.3
42456
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
410.0
|
6.8
|
L
 1.5%
H
6.5
7.0
|
L
 2.7%
H
6.1
7.6
|
L
 1211.5%
H
0.4
7.6
|
L
 949.2%
H
0.4
7.6
|
L
 424.6%
H
0.4
7.6
|
L
 37.2%
H
0.4
9.1
|
L
 -67.5%
H
0.4
21.5
|
L
 -99.5%
H
0.4
1887.7
|
| Sanmina Corp |
|
6,877.5
|
126.0
|
L
 -3.3%
H
125
129.0
|
L
 -0.3%
H
118.1
132.5
|
L
 -15.0%
H
118.1
165.9
|
L
 -16.9%
H
118.1
185.3
|
L
 61.0%
H
63.7
185.3
|
L
 122.0%
H
43.4
185.3
|
L
 206.8%
H
35.1
185.3
|
L
 467.9%
H
18.3
185.3
|
| Sight Sciences Inc |
|
189.0
|
3.5
|
L
 -2.0%
H
3.4
3.6
|
L
 -3.3%
H
3.4
4.0
|
L
 -36.0%
H
3.4
5.7
|
L
 -58.6%
H
3.4
9.2
|
L
 17.5%
H
2.0
9.2
|
L
 -61.3%
H
1.0
11.2
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
3,816.5
|
13.4
|
L
 -1.0%
H
13.4
13.6
|
L
 0.8%
H
13.3
14.0
|
L
 -22.9%
H
13.2
17.9
|
L
 -21.8%
H
13.2
19.9
|
L
 9.6%
H
9.5
19.9
|
L
 -25.9%
H
9.5
19.9
|
L
 -47.9%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
552.5
|
12.5
|
L
 -2.0%
H
12.5
12.8
|
L
 -9.5%
H
12.5
14.2
|
L
 -19.1%
H
12.5
16.9
|
L
 -38.6%
H
12.5
21.9
|
L
 -18.2%
H
12.5
21.9
|
L
 -36.1%
H
11.7
29.5
|
L
 -63.0%
H
11.1
37.2
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
9.4
|
2.4
|
L
 -5.8%
H
2.4
2.5
|
L
 -14.7%
H
2.4
3.0
|
L
 -24.1%
H
2.4
3.2
|
L
 -32.7%
H
2.4
4.1
|
L
 -18.7%
H
1.7
6.8
|
L
 -99.5%
H
0.1
494
|
L
 -100.0%
H
0.1
41308
|
L
 -100.0%
H
0.1
20160000
|
| Beauty Health Co (Class A) |
|
143.1
|
1.1
|
L
 -3.5%
H
1.1
1.2
|
L
 5.7%
H
1.1
1.4
|
L
 14.3%
H
0.9
1.4
|
L
 -26.8%
H
0.9
1.6
|
L
 -15.2%
H
0.8
2.7
|
L
 -90.1%
H
0.8
13.9
|
L
 -90.3%
H
0.8
30.2
|
L
H
0.8
30.2
|
| Sanara MedTech Inc |
|
167.3
|
18.7
|
L
H
18.7
19.3
|
L
 -1.9%
H
18.5
20.3
|
L
 -6.1%
H
18.5
21.2
|
L
 -22.7%
H
18.3
26.0
|
L
 -46.0%
H
18.3
36.0
|
L
 -53.2%
H
18.3
50.2
|
L
 -35.4%
H
17.4
50.2
|
L
 179.4%
H
2
75
|
| Sensus Healthcare Inc |
|
64.7
|
3.9
|
L
 -1.3%
H
3.9
3.9
|
L
 -1.3%
H
3.8
4.1
|
L
 0.5%
H
3.8
4.9
|
L
 2.6%
H
3.6
5.5
|
L
 -17.8%
H
3.0
5.9
|
L
 -23.1%
H
1.8
9.3
|
L
 -11.5%
H
1.8
15.3
|
L
H
1.8
15.3
|
| Staar Surgical Co. |
|
870.4
|
17.6
|
L
 0.6%
H
17.3
17.9
|
L
 -4.4%
H
17.2
19.4
|
L
 -1.7%
H
17.0
20.5
|
L
 -30.1%
H
15.6
25.7
|
L
 -3.7%
H
14.7
30.8
|
L
 -70.7%
H
13.5
73.1
|
L
 -81.8%
H
13.5
163.1
|
L
 133.8%
H
5.0
163.1
|
| Neuronetics Inc |
|
97.3
|
1.4
|
L
 -6.6%
H
1.4
1.5
|
L
 11.8%
H
0.8
1.5
|
L
 6.0%
H
0.8
1.5
|
L
 1.4%
H
0.8
2.3
|
L
 -71.7%
H
0.8
5.1
|
L
 -49.8%
H
0.5
5.9
|
L
 -89.4%
H
0.5
17.9
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
32.0
|
9.9
|
L
H
9.2
9.9
|
L
H
9.0
10.2
|
L
 -1.4%
H
9.0
10.3
|
L
 -9.4%
H
9.0
11.5
|
L
 348.9%
H
1.7
12.0
|
L
 133.4%
H
1.7
12.0
|
L
 -40.8%
H
1.7
23.4
|
L
 -96.0%
H
1.7
307.5
|
| Sharps Tech Inc |
|
53.9
|
1.9
|
L
 1.6%
H
1.8
1.9
|
L
 2.2%
H
1.8
2.1
|
L
 5.7%
H
1.7
2.1
|
L
 -16.2%
H
1.4
2.6
|
L
 -98.1%
H
0.0
95.7
|
L
 -100.0%
H
0.0
10428
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
600.2
|
26.8
|
L
 -1.2%
H
26.6
27.0
|
L
 -3.0%
H
26.3
28.0
|
L
 -5.3%
H
26.3
30.2
|
L
 -7.5%
H
26
37.8
|
L
 94.0%
H
8.6
37.8
|
L
 84.5%
H
8.6
37.8
|
L
 -49.7%
H
6.3
61.1
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
33.4
|
0.8
|
L
H
0.8
0.8
|
L
 -2.6%
H
0.7
0.9
|
L
 -6.3%
H
0.7
0.9
|
L
 -33.6%
H
0.7
1.2
|
L
 -68.2%
H
0.7
2.5
|
L
 -92.6%
H
0.7
11.6
|
L
 -95.2%
H
0.7
16.5
|
L
H
0.7
23.5
|
| Tivic Health Systems Inc |
|
2.3
|
0.9
|
L
 -1.1%
H
0.9
1.0
|
L
H
0.9
1.0
|
L
 12.2%
H
0.7
1.2
|
L
 -47.1%
H
0.7
2.5
|
L
 -73.6%
H
0.7
13.2
|
L
 -99.7%
H
0.7
404.4
|
L
H
0.7
11050
|
L
H
0.7
11050
|
| Treace Medical Concepts Inc |
|
82.0
|
1.3
|
L
 -3.1%
H
1.3
1.4
|
L
 -5.9%
H
1.3
1.5
|
L
 -33.9%
H
1.3
2.2
|
L
 -50.6%
H
1.3
3.1
|
L
 -84.5%
H
1.3
8.9
|
L
 -94.5%
H
1.3
28.0
|
L
H
1.3
37.2
|
L
H
1.3
37.2
|
| Transmedics Grp Inc |
|
3,867.6
|
112.8
|
L
 -0.9%
H
112.5
114.5
|
L
 -7.1%
H
110.2
128.2
|
L
 -15.2%
H
110.2
151
|
L
 -11.7%
H
110.2
151.9
|
L
 60.3%
H
62.2
156
|
L
 53.8%
H
36.4
177.4
|
L
 154.6%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,660.3
|
24.3
|
L
 -1.3%
H
23.9
24.7
|
L
 16.4%
H
20.9
25.4
|
L
 31.2%
H
20.2
29.7
|
L
 10.1%
H
17.7
29.7
|
L
 17.9%
H
10.0
29.7
|
L
 -40.9%
H
10.0
53.7
|
L
 -72.9%
H
10.0
155.9
|
L
 -75.7%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
12.3
|
0.7
|
L
H
0.6
0.7
|
L
 -5.8%
H
0.6
0.8
|
L
 -12.2%
H
0.6
0.8
|
L
 -27.8%
H
0.6
1.8
|
L
 -96.2%
H
0.6
86
|
L
 -99.9%
H
0.6
775
|
L
 -100.0%
H
0.6
2937.5
|
L
 -100.0%
H
0.6
8550
|
| Utah Medical Products Inc |
|
205.1
|
64.4
|
L
 0.6%
H
64.3
64.4
|
L
 2.8%
H
62.2
66.9
|
L
 -3.3%
H
62.2
68.7
|
L
 13.8%
H
55.8
68.7
|
L
 11.7%
H
51.3
68.7
|
L
 -30.4%
H
51.3
100.6
|
L
 -26.0%
H
51.3
133.9
|
L
 3.6%
H
51.3
133.9
|
| Vivani Medical Inc |
|
93.4
|
1.2
|
L
H
1.2
1.2
|
L
 3.6%
H
1.1
1.3
|
L
 -11.5%
H
1.1
1.3
|
L
 -17.3%
H
1.1
1.6
|
L
 4.6%
H
0.9
1.9
|
L
 11.7%
H
0.8
7.8
|
L
 -97.3%
H
0.8
43.4
|
L
 -99.0%
H
0.8
145.2
|
| Veracyte Inc |
|
2,538.7
|
32.0
|
L
 -2.5%
H
31.8
32.8
|
L
 3.3%
H
31.1
33.7
|
L
 -11.9%
H
30.6
39.9
|
L
 -25.6%
H
30.6
46.8
|
L
 0.5%
H
22.6
50.7
|
L
 42.4%
H
18.6
50.7
|
L
 -38.5%
H
14.9
59.8
|
L
 571.2%
H
4.2
86.0
|
| Varex Imaging Corp |
|
451.5
|
10.8
|
L
 -2.9%
H
10.8
11.1
|
L
 -0.8%
H
10.6
11.5
|
L
 -21.7%
H
10.6
13.9
|
L
 -12.4%
H
10.6
14.6
|
L
 -17.3%
H
6.8
14.6
|
L
 -40.6%
H
6.8
23.9
|
L
 -51.9%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
13.4
|
1.3
|
L
H
1.3
1.3
|
L
 -1.5%
H
1.2
1.5
|
L
 -21.5%
H
1.2
1.7
|
L
 -35.0%
H
1.2
2.7
|
L
 -63.7%
H
1.2
8.0
|
L
 -85.4%
H
1.2
48.8
|
L
 -99.3%
H
1.2
271.5
|
L
H
1.2
360.3
|
| Wrap Tech Inc |
|
81.2
|
1.5
|
L
 -1.3%
H
1.5
1.5
|
L
 -8.0%
H
1.5
1.7
|
L
 -16.3%
H
1.5
1.8
|
L
 -34.7%
H
1.5
3.2
|
L
 -27.7%
H
1.2
3.2
|
L
 -14.9%
H
1.0
7.0
|
L
 -73.6%
H
1.0
9.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
8.1
|
0.8
|
L
 -1.3%
H
0.8
0.8
|
L
 -4.9%
H
0.8
0.9
|
L
 -29.4%
H
0.8
1.1
|
L
 -15.4%
H
0.7
2.7
|
L
 -86.1%
H
0.7
6.4
|
L
 -99.4%
H
0.7
143.2
|
L
 -99.3%
H
0.7
328.2
|
L
H
0.7
900
|
| DENTSPLY Sirona Inc |
|
2,221.2
|
11.1
|
L
 -1.2%
H
11.1
11.3
|
L
 -5.8%
H
11.1
12.4
|
L
 -11.2%
H
11.1
14.8
|
L
 -0.8%
H
11.0
14.8
|
L
 -29.0%
H
9.9
17.2
|
L
 -69.8%
H
9.9
43.2
|
L
 -82.3%
H
9.9
69.5
|
L
 -81.7%
H
9.9
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
5.6
|
0.6
|
L
H
0.6
0.6
|
L
 -6.4%
H
0.6
0.7
|
L
 -33.7%
H
0.6
0.9
|
L
 -82.0%
H
0.5
3.3
|
L
 -87.1%
H
0.5
10.3
|
L
 -88.0%
H
0.5
20.0
|
L
 -95.6%
H
0.5
26.8
|
L
 -97.3%
H
0.5
31.4
|
| 111 Inc (ADR) |
|
55.9
|
6.5
|
L
 -2.1%
H
6.5
6.6
|
L
 -0.5%
H
6.3
6.9
|
L
 -22.0%
H
6.0
8.4
|
L
 74.8%
H
2.5
11.2
|
L
 -41.4%
H
2.5
11.3
|
L
 138.0%
H
0.4
11.3
|
L
 -60.2%
H
0.4
17.0
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
16.8
|
2.1
|
L
H
2.1
2.5
|
L
 -7.8%
H
2.0
2.9
|
L
 -23.6%
H
2.0
3.2
|
L
 -48.8%
H
2.0
5.4
|
L
 -89.5%
H
2.0
19.8
|
L
H
2.0
509.9
|
L
H
2.0
509.9
|
L
H
2.0
509.9
|
| HeartBeam Inc |
|
-
|
1.2
|
L
 -0.8%
H
1.2
1.3
|
L
 -15.7%
H
1.2
1.4
|
L
 -15.7%
H
1.2
1.8
|
L
 -60%
H
1.2
3.2
|
L
 -38%
H
0.5
4
|
L
 -21.5%
H
0.5
4
|
L
 -21.5%
H
0.5
4
|
L
 -21.5%
H
0.5
4
|
| Cencora |
|
63,901.4
|
328.5
|
L
 -1.0%
H
328.1
332.9
|
L
 -6.9%
H
318.1
356.1
|
L
 -8.5%
H
318.1
376.9
|
L
 -3.7%
H
318.1
376.9
|
L
 23.6%
H
264.3
377.5
|
L
 116.1%
H
150.3
377.5
|
L
 183.4%
H
111.3
377.5
|
L
 275.5%
H
68.4
377.5
|
| Incannex Healthcare Ltd (ADR) |
|
42.2
|
3.0
|
L
 -2.6%
H
3.0
3.1
|
L
 -2.0%
H
2.9
3.4
|
L
 -64.3%
H
2.9
9.3
|
L
 -77.0%
H
2.9
14.0
|
L
 -88.3%
H
2.4
49.8
|
L
 -98.2%
H
2.4
160.2
|
L
 -98.2%
H
2.4
160.2
|
L
 -98.2%
H
2.4
160.2
|
| Rewalk Robotics Ltd |
|
10.5
|
6.9
|
L
 1.3%
H
6.9
6.9
|
L
 4.1%
H
6.1
7.6
|
L
 10.7%
H
4.1
7.6
|
L
 -11.4%
H
4.1
9.0
|
L
 -66.7%
H
4.1
23.0
|
L
 -88.4%
H
4.1
109.2
|
L
 -97.3%
H
4.1
257.9
|
L
 -100.0%
H
4.1
22652.1
|
| Work Medical Tech Grp Ltd |
|
1.4
|
1.1
|
L
 -0.9%
H
1.1
1.1
|
L
 -2.6%
H
1.1
1.2
|
L
 -22.8%
H
1.1
1.5
|
L
 -78.9%
H
1.1
5.9
|
L
 -100.0%
H
1.1
10800
|
L
H
1.1
84460
|
L
H
1.1
84460
|
L
H
1.1
84460
|
| iTonic Holdings Ordinary |
|
4.8
|
0.3
|
L
 -6.7%
H
0.3
0.3
|
L
 -12.5%
H
0.3
0.3
|
L
 -28.2%
H
0.3
0.4
|
L
 -44%
H
0.3
1.1
|
L
 -93.4%
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
| Ceribell Inc |
|
705.0
|
18.7
|
L
 -1.6%
H
18.6
19.2
|
L
 2.0%
H
18.2
19.7
|
L
 -7.7%
H
16.8
20.5
|
L
 -11.7%
H
16.8
24.3
|
L
 -9.3%
H
10.0
24.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
563.9
|
5.8
|
L
 -1.5%
H
5.8
5.9
|
L
 -11.9%
H
5.8
6.7
|
L
 0.7%
H
5.7
7.0
|
L
 17.4%
H
4.4
7.0
|
L
 -6.6%
H
2.3
7.0
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
| Beta Bionics Inc |
|
475.3
|
10.7
|
L
 -0.8%
H
10.5
10.8
|
L
 5.9%
H
10.2
11.2
|
L
 -20.4%
H
9.9
14.1
|
L
 -63.4%
H
9.9
32.6
|
L
 -32.2%
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
| Wellgistics Health Inc |
|
10.8
|
0.1
|
L
H
0.1
0.1
|
L
 -29.4%
H
0.1
0.2
|
L
 -53.9%
H
0.1
0.3
|
L
 -75.5%
H
0.1
0.5
|
L
 -97.0%
H
0.1
7.0
|
L
H
0.1
7.0
|
L
H
0.1
7.0
|
L
H
0.1
7.0
|
| Kestra Medical Tech Ltd |
|
1,116.8
|
19.1
|
L
 -2.2%
H
18.8
20.6
|
L
 0.6%
H
17.7
22.2
|
L
 -27.3%
H
17.7
27.4
|
L
 -29.9%
H
17.7
28.8
|
L
 -16.8%
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
172.4
|
20.1
|
L
 -2.1%
H
19.6
20.5
|
L
 -6.0%
H
19.6
23.4
|
L
 -18.8%
H
19.6
25.6
|
L
 -37.7%
H
19.6
32.9
|
L
 -37.8%
H
19.6
46.6
|
L
 -37.8%
H
19.6
46.6
|
L
 -37.8%
H
19.6
46.6
|
L
 -37.8%
H
19.6
46.6
|
| SS Innovations Intl Inc |
|
1,000.7
|
5
|
L
 -0.2%
H
5
5
|
L
 0.8%
H
4.5
5.1
|
L
 13.6%
H
4.2
5.3
|
L
 -12.6%
H
3.1
6.2
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
35,306.7
|
43.5
|
L
 -0.2%
H
43.0
43.7
|
L
 5.9%
H
40.8
43.7
|
L
 -8.6%
H
40.8
50.9
|
L
 4.4%
H
38.5
50.9
|
L
 6.1%
H
38
50.9
|
L
 6.1%
H
38
50.9
|
L
 6.1%
H
38
50.9
|
L
 6.1%
H
38
50.9
|